A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 58
(10)
◽
pp. S236
Keyword(s):
2018 ◽
Vol 40
(12)
◽
pp. 2099-2111
◽
Keyword(s):
2018 ◽
Vol 26
(2)
◽
pp. 150-159
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol Volume 11
◽
pp. 275-281
Keyword(s):
Keyword(s):